PATENT CLAIM ANALYSIS

Application Number: 16117401
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["424", "172100"]

Abstract:
The present invention is directed to antibodies and fragments thereof having binding specificity for CGRP. Another embodiment of this invention relates to the antibodies described herein, and binding fragments thereof, comprising the sequences of the V H , V L  and CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates conjugates of anti-CGRP antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention also contemplates methods of making said anti-CGRP antibodies and binding fragments thereof. Embodiments of the invention also pertain to the use of anti-CGRP antibodies, and binding fragments thereof, for the diagnosis, assessment and treatment of diseases and disorders associated with CGRP.

Claim (Index 227):
The method of  claim 212 , wherein the composition is an aqueous solution.

Metadata:
- Claim Count in Document: 119.0
- Percentile: 96.0
- Lexical Diversity: 2.11864
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15892804', '15892956', '15892858', '15257562', '13476465']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.859692697366616
- 35 USC 102 Novelty (BERT): 0.6067342298777996
- Combined Prediction Score: 0.8343968506177344
- Mean Citation Score: 913.56305
- Max Citation Score: 940.6963
- Similarity Product: 485.467221913129

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test